Impact of treatment of rheumatoid arthritis on periodontal disease: A review.
Catherine PetitShauna CulshawRoland WeigerOlivier HuckPhilipp SahrmannPublished in: Molecular oral microbiology (2024)
Within the limitations of the available studies, there is evidence to suggest that bDMARD monotherapy may improve the periodontal condition of RA patients with periodontal disease to a certain extent; the concomitant medication of TNF inhibitor + MTX could worsen gingival inflammation. More data are required to understand the impact of RA therapies on periodontal health.
Keyphrases
- rheumatoid arthritis
- disease activity
- healthcare
- ankylosing spondylitis
- interstitial lung disease
- combination therapy
- oxidative stress
- public health
- electronic health record
- health information
- mental health
- big data
- randomized controlled trial
- adverse drug
- emergency department
- clinical trial
- open label
- case control
- social media
- systemic sclerosis
- data analysis
- study protocol
- drug induced
- replacement therapy